Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Connie Matsui Insider Profile
4 Followers
Connie Matsui, Director at Halozyme, holds 183.03K shares in Halozyme (Ticker: HALO), holds ― shares in Sutro Biopharma (Ticker: STRO), holds 56.67K shares in Artelo Biosciences (Ticker: ARTL).
Profitable Transactions
1 out of 4 Profitable Transactions
Average Return
-25.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Connie Matsui holds in companies
Most Profitable Insider Trade
The most profitable trade made by Connie Matsui
Connie Matsui's Trading History
Halozyme
Dec 03, 2024
Director
Uninformative Sell
―
$10.03M
Sutro Biopharma
―
Director
―
―
Artelo Biosciences
May 04, 2020
Director
Informative Buy
50.00K
$65.17K
Biogen
―
EVP, Corp. Strategy and Comm.
―
$8.94M
List of latest transactions for each holding click on a transaction to see Connie Matsui's performance on stock
You May Also Like
Connie Matsui insider profile FAQ
What is the percentage of profitable transactions made by Connie Matsui?
The percentage of profitable transactions made by Connie Matsui is 25%.
What is the average return per transaction made by Connie Matsui?
The average return per transaction made by Connie Matsui is -25.40%.
What stocks does Connie Matsui hold?
Connie Matsui holds: HALO, STRO, ARTL, BIIB stocks.
What was Connie Matsui’s latest transaction?
Connie Matsui latest transaction was an Uninformative Sell of ―.
What was Connie Matsui's most profitable transaction?
Connie Matsui’s most profitable transaction was an Informative Buy of ARTL stock on May 4, 2020. The return on the trade was 1.50%.
What is Connie Matsui's role in Halozyme?
Connie Matsui's role in Halozyme is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.